Need for a risk-based control strategy for managing glycosylation profile for biosimilar products

.

Source: Expert Opinion on Biological Therapy - September 1, 2021 Category: Drugs & Pharmacology Authors: Anurag Rathore Himanshu Malani Source Type: research